Filtros de búsqueda

Lista de obras de

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

artículo científico publicado en 2017

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

artículo científico publicado en 2017

8. Allostatic Load is Associated With Positive Symptoms in Schizophrenia and First-Episode Psychosis and Decreases With Antipsychotic Therapy.

artículo científico publicado en 2017

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

artículo científico publicado en 2010

A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

artículo científico publicado en 2016

Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning

artículo científico publicado en 2012

Affect recognition and functioning in putatively prodromal individuals.

artículo científico publicado en 2013

Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care

artículo científico publicado en 2011

Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis

artículo científico publicado en 2018

Antibodies to Infectious Agents in Individuals at Ultra-High Risk for Psychosis

scientific article published on 03 January 2007

Are current labeling terms suitable for people who are at risk of psychosis?

artículo científico publicado en 2017

Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia

artículo científico publicado en 2015

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

artículo científico publicado en 2015

Back to the future: predicting and reshaping the course of psychotic disorder

artículo científico publicado en 2008

Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes

artículo científico publicado en 2019

Bioactive lipids in schizophrenia

artículo científico publicado en 2006

Biomarkers and clinical staging in psychiatry

artículo científico publicado en 2014

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk

artículo científico publicado en 2017

Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol

scientific article published on 29 November 2018

Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance

scientific article published on 28 November 2018

Changes in triglyceride levels in ultra-high risk for psychosis individuals treated with omega-3 fatty acids.

artículo científico publicado en 2015

Clinical trajectories in the ultra-high risk for psychosis population

artículo científico publicado en 2018

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

artículo científico publicado en 2020

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

artículo científico publicado en 2020

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

artículo científico publicado en 2019

Correlates of electroencephalographic resting states and erythrocyte membrane docosahexaenoic and eicosapentaenoic acid levels in individuals at ultra-high risk of psychosis.

artículo científico publicado en 2015

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

artículo científico publicado en 2020

Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis.

artículo científico publicado en 2016

Cross-sectional association of seafood consumption, polyunsaturated fatty acids and depressive symptoms in two Torres Strait communities

artículo científico publicado en 2018

Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?

scientific article published on 19 October 2018

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals

artículo científico publicado en 2011

Delayed sleep onset in depressed young people.

artículo científico publicado en 2014

Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study

artículo científico publicado en 2014

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

scientific article published on 26 August 2020

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

artículo científico publicado en 2016

Disturbed glutathione antioxidative defense is associated with structural brain changes in neuroleptic-naïve first-episode psychosis patients

artículo científico publicado en 2017

Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?

scientific article published on 15 April 2020

Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?

scientific article published on May 2009

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 y

artículo científico publicado en 2008

Dr McGorry and colleagues reply.

artículo científico publicado en 2013

Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia

scientific article published on 01 April 2002

Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis

artículo científico publicado en 2017

Duration of untreated psychosis in a high-income versus a low- and middle-income region.

artículo científico publicado en 2013

Dynamic prediction of transition to psychosis using joint modelling

artículo científico publicado en 2018

Dysregulated Lipid Metabolism Precedes Onset of Psychosis

scientific article published on 25 July 2020

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

scientific article published on 28 November 2019

Early Psychosis Prevention and Intervention Centre long-term follow-up study of first-episode psychosis: methodology and baseline characteristics.

artículo científico publicado en 2007

Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals

artículo científico publicado en 2006

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?

artículo científico publicado en 2013

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

artículo científico publicado en 2016

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. ⬇️

artículo científico publicado en 2013

Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.

artículo científico

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

artículo científico publicado en 2015

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

artículo científico publicado en 2014

Emotion recognition in individuals at clinical high-risk for schizophrenia.

artículo científico publicado en 2011

Emotion recognition in unaffected first-degree relatives of individuals with first-episode schizophrenia

artículo científico publicado en 2014

Erratum to: A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

artículo científico publicado en 2017

Erythrocyte glutathione levels as long-term predictor of transition to psychosis

artículo científico publicado en 2017

Estimating cognitive deterioration in schizophrenia

artículo científico publicado en 2002

Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study

artículo científico publicado en 2008

Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.

artículo científico

Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group.

artículo científico publicado en 2010

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS.

artículo científico publicado en 2018

Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls

artículo científico publicado en 2012

From neuroprogression to neuroprotection: implications for clinical care.

artículo científico publicado en 2010

Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis

artículo científico publicado en 2012

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning

scientific article published on 06 February 2019

Früherkennung und Frühintervention der Schizophrenie

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study

scientific article published on 07 May 2019

Global research priorities for youth mental health

scientific article published on 01 February 2020

Hair cortisol, allostatic load, and depressive symptoms in Australian Aboriginal and Torres Strait Islander people

scientific article published on 05 March 2019

Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?

artículo científico publicado en 2020

Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification

artículo científico publicado en 2015

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

artículo científico publicado en 2014

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis

scientific article published on 01 January 2022

Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder.

artículo científico publicado en 2014

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis

artículo científico publicado en 2017

In vivo imaging of oxidative stress and fronto-limbic white matter integrity in young adults with mood disorders

artículo científico publicado en 2017

Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial

artículo científico publicado en 2014

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

artículo científico publicado en 2009

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

artículo científico publicado en 2010

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study

artículo científico publicado en 2013

Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study

artículo científico publicado en 2015

Longitudinal sex differences of externalising and internalising depression symptom trajectories: Implications for assessment of depression in men from an online study

artículo científico publicado en 2014

Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial

artículo científico publicado en 2022

Men's perceived barriers to help seeking for depression: Longitudinal findings relative to symptom onset and duration

artículo científico publicado en 2015

Metabolic changes in first‐episode early‐onset schizophrenia with second‐generation antipsychotics ⬇️

artículo científico publicado el 22 de agosto de 2013

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

artículo científico publicado en 2015

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.

artículo científico publicado en 2018

Negative Psychosis Prevention Trials-Reply

artículo científico publicado en 2017

Negative and Positive Dimensions of Schizotypal Personality Disorder

artículo científico publicado el 1 de enero de 1997

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

artículo científico publicado en 2018

Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study.

artículo científico publicado en 2012

Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis

artículo científico publicado en 2016

Novel biotherapies are needed in youth mental health.

artículo científico publicado en 2017

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS.

artículo científico publicado en 2018

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL.

artículo científico publicado en 2018

Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis

artículo científico publicado en 2013

Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.

artículo científico publicado en 2013

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

artículo científico publicado en 2020

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study

artículo científico publicado en 2006

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study

artículo científico

Online and social networking interventions for the treatment of depression in young people: a systematic review

artículo científico publicado en 2014

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

artículo científico publicado en 2017

Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study

artículo científico publicado en 2011

PACE: a specialised service for young people at risk of psychotic disorders

artículo científico publicado en 2007

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.

artículo científico publicado en 2017

PM396. Associations of obsessive–compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness.

artículo científico publicado en 2016

Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence

artículo científico publicado en 2016

Polyunsaturated fatty acids in emerging psychosis

artículo científico

Polyunsaturated fatty acids in emerging psychosis: a safer alternative?

artículo científico

Prediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis.

artículo científico publicado en 2010

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

scientific article published on 17 June 2020

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers

scientific article published on 20 September 2016

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

artículo científico publicado en 2017

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

artículo científico publicado en 2015

Premorbid adjustment and remission of positive symptoms in first-episode psychosis ⬇️

artículo científico publicado el 1 de diciembre de 1997

Premorbid performance IQ deficit in schizophrenia

artículo científico publicado en 2000

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis

artículo científico publicado en 2012

Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis

artículo científico

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics

artículo científico publicado en 2009

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

artículo científico publicado en 2019

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study

artículo científico publicado en 2016

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

artículo científico publicado en 2018

Relationship between amygdala volume and emotion recognition in adolescents at ultra-high risk for psychosis

artículo científico publicado en 2014

Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis.

artículo científico publicado en 2014

Resting-state functional brain networks in first-episode psychosis: A 12-month follow-up study

article by Eleni P Ganella et al published September 2018 in Australian and New Zealand Journal of Psychiatry

Review: limited evidence from two small trials suggests no improvement in ASD symptoms with short term ω-3 supplementation ⬇️

artículo científico publicado el 2 de marzo de 2012

Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years.

artículo científico publicado en 2011

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

artículo científico publicado en 2018

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS.

artículo científico publicado en 2018

Self reported rates of criminal offending and victimization in young people at-risk for psychosis.

artículo científico publicado en 2015

Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population.

artículo científico publicado en 2013

Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.

artículo científico

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

artículo científico publicado en 2017

State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.

artículo científico publicado en 2017

Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis

artículo científico publicado en 2012

Substance use in youth at risk for psychosis

artículo científico publicado en 2016

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

scientific article published on 09 October 2019

T159. ASSOCIATION BETWEEN VITAMIN D INSUFFICIENCY AND METABOLIC SYNDROME IN PATIENTS WITH PSYCHOTIC DISORDERS.

artículo científico publicado en 2018

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

artículo científico publicado en 2018

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

artículo científico publicado en 2018

Testing the Effects of Dietary Seafood Consumption on Depressive Symptoms

artículo científico publicado en 2020

The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis

artículo científico publicado en 2012

The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission

artículo científico publicado en 2010

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

artículo científico publicado en 2019

The New York high-risk project: social and general intelligence in children at risk for schizophrenia ⬇️

artículo científico publicado el 4 de mayo de 1998

The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.

artículo científico publicado en 2017

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial

artículo científico publicado en 2014

The prognostic significance of attenuated psychotic symptoms in help-seeking youth

scientific article published on 12 October 2019

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

scientific article published on 21 November 2019

Transitions Study of predictors of illness progression in young people with mental ill health: study methodology.

artículo científico publicado en 2013

Update on ω-3 polyunsaturated fatty acids in early-stage psychotic disorders

artículo científico publicado en 2012

Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values.

artículo científico publicado en 2017

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.

artículo científico publicado en 2016

White matter connectivity disruptions in early and chronic schizophrenia

artículo científico publicado en 2017

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.

artículo científico publicado en 2016

Whither the attenuated psychosis syndrome?

artículo científico publicado en 2012

Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin

scientific article published on 17 January 2020

Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin.

artículo científico publicado en 2015

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.

artículo científico publicado en 2014

[Early detection of psychotic disorders]

scientific article published on 01 January 2007

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda